<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Evaluation of occult gastrointestinal bleeding</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Evaluation of occult gastrointestinal bleeding</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Evaluation of occult gastrointestinal bleeding</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Molly Perencevich, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John R Saltzman, MD, FACP, FACG, FASGE, AGAF</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J Thomas Lamont, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anne C Travis, MD, MSc, FACG, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 22, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Occult gastrointestinal (GI) bleeding refers to the initial presentation of a positive fecal occult blood test result and/or iron deficiency anemia when there is no evidence of visible blood loss to the patient or physician [<a href="#rid1">1</a>]. By contrast, the term overt is used to describe blood loss that is visible to the patient or clinician. Overt bleeding may manifest as hematemesis, melena, or hematochezia.<strong> </strong></p><p>The major cause of iron deficiency in developed countries is blood loss [<a href="#rid2">2</a>]. In male patients, the blood loss is most commonly from the GI tract; in premenopausal female patients, menstrual blood loss must also be considered [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/d/html/7150.html" rel="external">"Causes and diagnosis of iron deficiency and iron deficiency anemia in adults"</a>.)</p><p>The initial evaluation of patients with occult GI bleeding will be reviewed here. The evaluation of patients with overt GI bleeding, the evaluation for occult GI blood loss as it relates to screening for colorectal cancer, and the evaluation of patients with suspected small bowel bleeding (previously referred to as obscure GI bleeding) are discussed separately. (See  <a class="medical medical_review" href="/d/html/2625.html" rel="external">"Evaluation of suspected small bowel bleeding (formerly obscure gastrointestinal bleeding)"</a> and  <a class="medical medical_review" href="/d/html/2547.html" rel="external">"Approach to acute lower gastrointestinal bleeding in adults"</a> and  <a class="medical medical_review" href="/d/html/2548.html" rel="external">"Approach to acute upper gastrointestinal bleeding in adults"</a> and  <a class="medical medical_review" href="/d/html/7576.html" rel="external">"Tests for screening for colorectal cancer"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">CAUSES OF OCCULT GI BLEEDING</span><span class="headingEndMark"> — </span>The differential diagnosis for occult GI bleeding is broad  (<a class="graphic graphic_table graphicRef69451" href="/d/graphic/69451.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef104990" href="/d/graphic/104990.html" rel="external">table 2</a>). Some of the more common causes include colon cancer, esophagitis, peptic ulcers, gastritis, inflammatory bowel disease, vascular ectasias, portal hypertensive gastropathy, gastric antral vascular ectasias, and small bowel tumors (eg, GI stromal cell tumor, lymphoma, carcinoid, adenocarcinoma, or polyp). However, less common causes, such as gastroesophageal cancers, hemosuccus pancreaticus, hemobilia, endometriosis, and infections also need to be considered. In addition, hemorrhoids can rarely lead to a positive fecal occult blood test [<a href="#rid4">4</a>]. While overt bleeding from hemorrhoids can result in anemia, anemia in the setting of occult GI bleeding should not be attributed to hemorrhoids. Non-GI sources of blood loss, such as hemoptysis and epistaxis, can also cause a positive fecal occult blood test.</p><p>The medical history and physical examination can help focus the differential diagnosis. As examples, colon cancer is a likely cause in patients older than 50 years, small bowel tumors are often seen in patients under the age of 40 years, and angiodysplasias are seen in association with several conditions, including aortic stenosis, renal disease, and presence of a left ventricular assist device. The presence of oral telangiectasias may signal the presence of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome), and mucocutaneous pigmentation may be due to Peutz-Jeghers syndrome in which hamartomatous polyps may ulcerate and cause occult GI bleeding. (See  <a class="medical medical_review" href="/d/html/2644.html" rel="external">"Causes of upper gastrointestinal bleeding in adults"</a> and  <a class="medical medical_review" href="/d/html/2546.html" rel="external">"Etiology of lower gastrointestinal bleeding in adults"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">TESTING FOR OCCULT BLOOD</span><span class="headingEndMark"> — </span>Testing for occult blood is stool-based and should be done with high sensitivity tests for fecal occult blood or immunochemical tests. Overall, fecal occult blood testing has a sensitivity of 58 percent and a specificity of 84 percent for detecting a source of iron deficiency anemia [<a href="#rid5">5</a>]. Of note, fecal immunohistochemical testing detects only human globin and therefore does not detect upper GI bleeding (since the globin is digested in transit). (See  <a class="medical medical_review" href="/d/html/7576.html" rel="external">"Tests for screening for colorectal cancer", section on 'Stool-based tests'</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">EVALUATION OF A POSITIVE FECAL OCCULT BLOOD TEST</span></p><p class="headingAnchor" id="H992491"><span class="h2">General approach</span><span class="headingEndMark"> — </span>The evaluation of a patient with a positive fecal occult blood test depends upon whether iron deficiency anemia is present  (<a class="graphic graphic_algorithm graphicRef94181" href="/d/graphic/94181.html" rel="external">algorithm 1</a>) [<a href="#rid1">1,6</a>]. Patients without iron deficiency anemia can be evaluated with colonoscopy, with or without upper endoscopy (depending on the patient's symptoms). Patients with iron deficiency anemia require a more extensive evaluation, including upper endoscopy and colonoscopy. If upper endoscopy and colonoscopy do not reveal a source of the bleeding, the next step is evaluation of the small bowel, typically with wireless capsule endoscopy.</p><p class="headingAnchor" id="H992944"><span class="h3">Iron deficiency anemia absent</span><span class="headingEndMark"> — </span>A patient with a positive fecal occult blood test and no anemia should undergo a colonoscopy [<a href="#rid1">1,6</a>]. If the patient has upper GI symptoms, an upper endoscopy should also be performed. If initial testing is negative and there are no signs of ongoing blood loss, further evaluation is not recommended.</p><p class="headingAnchor" id="H992510"><span class="h3">Iron deficiency anemia present</span><span class="headingEndMark"> — </span>A patient with a positive fecal occult blood test and iron deficiency anemia should undergo upper endoscopy and colonoscopy [<a href="#rid1">1,6</a>]. Since there is often uncertainty as to whether a positive finding on one endoscopic examination represents the true cause of bleeding, both examinations are recommended in the majority of cases. However, the risks of diagnostic testing must be weighed against those of missing important lesions.</p><p>Patients without a lesion identified on standard endoscopic evaluation (assuming the examinations were adequate) should have a small bowel examination. The small bowel examination of choice in the majority of patients is wireless capsule endoscopy. If the initial evaluation with upper endoscopy, colonoscopy, and capsule endoscopy is unrevealing, alternative non-GI sources for the patient’s iron deficiency should be considered. If the suspicion for a GI source of blood loss remains high, additional testing is indicated. (See <a class="local">'Small bowel evaluation'</a> below and  <a class="medical medical_review" href="/d/html/7150.html" rel="external">"Causes and diagnosis of iron deficiency and iron deficiency anemia in adults"</a> and  <a class="medical medical_review" href="/d/html/2625.html" rel="external">"Evaluation of suspected small bowel bleeding (formerly obscure gastrointestinal bleeding)"</a>.)</p><p class="headingAnchor" id="H992963"><span class="h2">Diagnostic tests</span></p><p class="headingAnchor" id="H8"><span class="h3">Upper endoscopy</span><span class="headingEndMark"> — </span>Important lesions in the upper digestive tract are frequently detected in patients who test positive for fecal occult blood or have iron deficiency anemia  (<a class="graphic graphic_picture graphicRef68358" href="/d/graphic/68358.html" rel="external">picture 1</a>). While the presence of symptoms referable to the upper GI tract has been associated with the detection of corresponding findings, even in patients without symptoms, the prevalence of lesions in the upper GI tract is greater than or equal to that of colonic lesions [<a href="#rid7">7-10</a>]. (See  <a class="medical medical_review" href="/d/html/13928.html" rel="external">"Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)"</a>.)</p><p>A number of studies have evaluated the yield of performing upper endoscopy or small bowel examination in patients who have a positive test for occult blood, iron deficiency anemia, or both [<a href="#rid11">11-15</a>]. In a meta-analysis of 21 studies of patients with a positive fecal occult blood test, clinically significant upper GI lesions were detected in 31 percent of patients [<a href="#rid16">16</a>]. Upper GI cancers were found in 0.8 percent, whereas nonmalignant lesions were found in 30 percent. Nine of the studies compared patients with and without anemia, and patients with anemia were more likely than those without anemia to have clinically significant lesions (OR 4.3, 95% CI 2.2-8.4, p = 0.0001), including upper GI cancer (OR 6.3, 95% CI 1.3-32, p = 0.025). GI symptoms, however, were not associated with upper GI lesions (OR 1.3, 95% CI 0.6-2.8, p = 0.51). Clinically significant upper GI lesions were found in 33 percent of patients with positive findings during colonoscopy. In individual studies, the proportion of patients with both upper and lower GI lesions ranged from 5 to 17 percent [<a href="#rid12">12,14,15</a>].</p><p>If no visible lesions or gastritis are seen during the upper endoscopy, biopsies should be taken from the stomach to exclude <em>H. pylori</em> infection, which has been associated with iron deficiency anemia, and from the small bowel to exclude celiac disease [<a href="#rid17">17</a>]. </p><p class="headingAnchor" id="H9"><span class="h3">Colonoscopy</span><span class="headingEndMark"> — </span>Because of the high prevalence of colorectal cancer and adenomatous polyps in developed countries, most patients should undergo colonoscopy. Colonoscopy is the preferred modality for evaluating the colon because it can detect a wide range of lesions, including polyps, cancers, and angiodysplasias. Colonoscopy also permits therapeutic intervention.</p><p>Radiographic studies (including <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> enemas and computed tomographic [CT] colonography, also called "virtual colonoscopy") do not offer the option of biopsy or polypectomy. However, they may have a role in selected patients. (See  <a class="medical medical_review" href="/d/html/2526.html" rel="external">"Overview of computed tomographic colonography"</a>.)</p><p class="headingAnchor" id="H10"><span class="h3">Small bowel evaluation</span><span class="headingEndMark"> — </span>If complete endoscopy and colonoscopy with adequate visualization do not reveal the source of the bleeding, additional evaluation is recommended  (<a class="graphic graphic_algorithm graphicRef95608" href="/d/graphic/95608.html" rel="external">algorithm 2</a>). While an upper GI series with a small bowel follow-through and/or enteroclysis was traditionally the next test performed, wireless capsule endoscopy, CT enterography, and magnetic resonance (MR) enterography have replaced these modalities [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/d/html/2625.html" rel="external">"Evaluation of suspected small bowel bleeding (formerly obscure gastrointestinal bleeding)"</a>.)</p><p>Wireless capsule endoscopy is generally the test of choice for evaluating suspected small bowel bleeding in patients who have had an adequate upper endoscopy and colonoscopy. Its main advantages are that it is noninvasive and permits examination of the entire length of the small bowel most of the time. Its main disadvantages are that it does not permit tissue sampling or therapeutic intervention and that not all of the small bowel mucosa is visualized. Patients at risk for capsule retention due to possible small bowel strictures should undergo small bowel imaging (eg, CT or MR enterography) or a patency capsule study prior to capsule endoscopy. A more detailed discussion of capsule endoscopy can be found elsewhere. (See  <a class="medical medical_review" href="/d/html/2662.html" rel="external">"Wireless video capsule endoscopy"</a>.)</p><p>CT enterography involves ingestion of a neutral contrast agent to distend the small bowel, followed by CT imaging of the abdomen. Using neutral contrast allows for better evaluation of the wall of the small bowel, which is difficult to see when standard <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> solutions are used.</p><p>MR enterography is an alternative to CT enterography. It has the advantage of not using ionizing radiation, which allows for sequential imaging of the small bowel. Like CT enterography, a neutral contrast agent (often polyethylene glycol) is used to distend the small bowel.</p><p>Other methods available for evaluating the small bowel include push enteroscopy, deep small bowel enteroscopy, and intraoperative enteroscopy. (See  <a class="medical medical_review" href="/d/html/2625.html" rel="external">"Evaluation of suspected small bowel bleeding (formerly obscure gastrointestinal bleeding)"</a>.)</p><p class="headingAnchor" id="H53808641"><span class="h1">EVALUATION OF ISOLATED IRON DEFICIENCY ANEMIA</span><span class="headingEndMark"> — </span>Patients with unexplained iron deficiency anemia but a negative fecal occult blood test should be evaluated for a GI source of blood loss  (<a class="graphic graphic_algorithm graphicRef94181" href="/d/graphic/94181.html" rel="external">algorithm 1</a>). This is particularly important in male patients and postmenopausal female patients. Patients with isolated iron deficiency anemia should be evaluated for celiac disease if an alternative source of blood loss is not identified. (See  <a class="medical medical_review" href="/d/html/4771.html" rel="external">"Diagnosis of celiac disease in adults"</a>.) </p><p>If patients have symptoms suggesting either an upper or lower GI source, it is reasonable to start the evaluation with an upper endoscopy or colonoscopy, respectively [<a href="#rid19">19</a>]. For patients who are asymptomatic, a colonoscopy is often the first test obtained, but in patients with anemia, we typically start the evaluation with both an upper endoscopy and a colonoscopy. (See <a class="local">'Diagnostic tests'</a> above and  <a class="medical medical_review" href="/d/html/7150.html" rel="external">"Causes and diagnosis of iron deficiency and iron deficiency anemia in adults"</a> and  <a class="medical medical_review" href="/d/html/4771.html" rel="external">"Diagnosis of celiac disease in adults"</a>.)</p><p>If patients do not undergo both an upper endoscopy and colonoscopy initially and no lesion is identified during the initial examination that explains the anemia, the other test (either an upper endoscopy or colonoscopy) should be performed. If both upper endoscopy and colonoscopy are negative, additional testing such as wireless capsule endoscopy should be pursued  (<a class="graphic graphic_algorithm graphicRef95608" href="/d/graphic/95608.html" rel="external">algorithm 2</a>). (See  <a class="medical medical_review" href="/d/html/2625.html" rel="external">"Evaluation of suspected small bowel bleeding (formerly obscure gastrointestinal bleeding)"</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">SPECIAL SITUATIONS</span></p><p class="headingAnchor" id="H12"><span class="h2">Patients with a known risk factor for gastrointestinal blood loss</span><span class="headingEndMark"> — </span>A positive fecal occult blood test should not be attributed to GI lesions that are infrequently associated with occult bleeding (eg, esophageal varices and colonic diverticula). It is rare for esophagogastric varices to cause occult GI bleeding, with the possible exception of varices that have been treated with endoscopic sclerosis or banding (which is transient and should resolve after the associated ulcers have healed). Similarly, most patients with bleeding colonic diverticular disease present with overt, rather than occult, bleeding. (See  <a class="medical medical_review" href="/d/html/2633.html" rel="external">"Clinical manifestations and diagnosis of acute colonic diverticulitis in adults"</a> and  <a class="medical medical_review" href="/d/html/2641.html" rel="external">"Colonic diverticular bleeding"</a>.)</p><p>Thus, in a patient with known esophagogastric varices or colonic diverticula, a positive test for occult blood or otherwise unexplained iron deficiency anemia should not preclude a diagnostic evaluation. Colonic diverticula commonly occur in the age bracket with the highest incidence of colon cancer, and colon cancer is far more likely to bleed in an occult manner.</p><p class="headingAnchor" id="H13"><span class="h2">Aspirin, antiplatelet agents, and anticoagulants</span><span class="headingEndMark"> — </span>Data are conflicting regarding the effect of antiplatelet agents and anticoagulants on fecal occult blood testing [<a href="#rid20">20-23</a>]. It should <strong>not</strong> be assumed that a positive test in a patient on one of these agents is a false-positive. </p><p class="bulletIndent1"><span class="glyph">●</span>In one study, the use of <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a>, nonsteroidal antiinflammatory agents, <a class="drug drug_general" data-topicid="8921" href="/d/drug information/8921.html" rel="external">clopidogrel</a>, or <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a> was associated with lower positive predictive values of fecal occult blood testing for advanced colorectal neoplasia compared with patients not taking these agents (21, 19, 7, and 20 percent, respectively, versus 31 percent) [<a href="#rid20">20</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a second study, the use of low-dose <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> was associated with an increased sensitivity for detecting advanced colorectal neoplasms with only a slight decrease in specificity [<a href="#rid22">22</a>].</p><p></p><p class="headingAnchor" id="H53808810"><span class="h2">Alcohol abuse</span><span class="headingEndMark"> — </span>The presence of fecal occult blood should not be attributed to alcohol ingestion alone unless coexistent pathology has been excluded. In a study of 1000 patients hospitalized for alcohol detoxification, 22 patients (2.2 percent) without overt GI bleeding tested positive for occult blood [<a href="#rid24">24</a>]. The subsequent endoscopic evaluation found that 24 percent of these individuals had peptic ulcer disease, 32 percent had premalignant colonic neoplasia, and all had upper GI mucosal inflammation.</p><p class="headingAnchor" id="H14"><span class="h2">Premenopausal female patients</span><span class="headingEndMark"> — </span>The optimal approach to iron deficiency anemia in female patients who continue to menstruate is uncertain. In one series, a clinically important lesion was detected in 23 of 186 premenopausal female patients (12 percent) who underwent endoscopy [<a href="#rid25">25</a>]. The most common source of bleeding was in the upper GI tract, including peptic ulcer disease (3 percent) and gastric cancer (3 percent). On multivariable analysis, independent predictors of a significant finding on endoscopy included a positive fecal occult blood test, hemoglobin &lt;10 g/dL, and abdominal symptoms. Another study of 187 premenopausal female patients found an exclusive and possible GI cause for iron deficiency anemia in 27 and 35 percent of patients, respectively [<a href="#rid26">26</a>].</p><p>While the high prevalence of positive findings in these studies may have reflected referral bias, endoscopic evaluation should be obtained if a fecal occult blood test is positive, if the iron deficiency anemia is out of proportion to menstrual blood loss, if the patient has abdominal symptoms, or if the patient has a family history of GI malignancy in a first-degree relative, particularly if the patient is older than 40 years of age.</p><p class="headingAnchor" id="H2919497412"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/114134.html" rel="external">"Society guideline links: Gastrointestinal bleeding in adults"</a>.)</p><p class="headingAnchor" id="H9072216"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15732.html" rel="external">"Patient education: Upper endoscopy (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/15413.html" rel="external">"Patient education: Colonoscopy (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/17182.html" rel="external">"Patient education: Angiodysplasia of the GI tract (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/1992.html" rel="external">"Patient education: Upper endoscopy (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/d/html/2002.html" rel="external">"Patient education: Colonoscopy (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H15"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations and detection</strong> – Occult bleeding refers to the initial presentation of a positive fecal occult blood test and/or iron deficiency anemia when there is no evidence of visible blood loss to the patient or clinician. By contrast, the term overt is used to describe blood loss that is visible to the patient or clinician. Overt bleeding may manifest as hematemesis, melena, or hematochezia. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1">Testing for occult bleeding should be done with high sensitivity tests for fecal occult blood or immunochemical tests. (See  <a class="medical medical_review" href="/d/html/7565.html" rel="external">"Screening for colorectal cancer: Strategies in patients at average risk", section on 'Choosing a screening test'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation </strong>–<strong> </strong>The initial evaluation depends on whether the patient has iron deficiency:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients without iron deficiency – Patients with a positive fecal occult blood test but without iron deficiency anemia should be evaluated by colonoscopy. If upper gastrointestinal (GI) tract symptoms are present, an upper endoscopy should also be performed. If the endoscopic evaluation is negative and there are no signs of ongoing blood loss, additional testing usually is not recommended  (<a class="graphic graphic_algorithm graphicRef94181" href="/d/graphic/94181.html" rel="external">algorithm 1</a>). (See <a class="local">'General approach'</a> above and <a class="local">'Diagnostic tests'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with iron deficiency – Patients with a positive fecal occult blood test and iron deficiency anemia should be evaluated with upper endoscopy and colonoscopy  (<a class="graphic graphic_algorithm graphicRef94181" href="/d/graphic/94181.html" rel="external">algorithm 1</a>). If these studies are unrevealing, we recommend evaluation for a small bowel source of bleeding, preferably with wireless capsule endoscopy. (See <a class="local">'General approach'</a> above and <a class="local">'Diagnostic tests'</a> above and  <a class="medical medical_review" href="/d/html/2625.html" rel="external">"Evaluation of suspected small bowel bleeding (formerly obscure gastrointestinal bleeding)"</a>.)</p><p></p><p class="bulletIndent2">Most patients with iron deficiency anemia but a negative fecal occult blood test should also undergo an upper endoscopy and colonoscopy. Possible exceptions are patients with a clear alternative explanation for their iron deficiency anemia (eg, celiac disease or significant hematuria) and asymptomatic, young female patients who continue to menstruate and have mild iron deficiency, provided there is no family history of GI malignancy in a first-degree relative. (See <a class="local">'Evaluation of isolated iron deficiency anemia'</a> above and <a class="local">'Premenopausal female patients'</a> above.)</p><p></p><p class="bulletIndent2">If the initial evaluation with upper endoscopy, colonoscopy, and capsule endoscopy is unrevealing, alternative non-GI sources for the patient's iron deficiency should be considered. If the suspicion for a GI source of blood loss remains high, additional testing is indicated. (See  <a class="medical medical_review" href="/d/html/7150.html" rel="external">"Causes and diagnosis of iron deficiency and iron deficiency anemia in adults"</a> and <a class="local">'General approach'</a> above and  <a class="medical medical_review" href="/d/html/2625.html" rel="external">"Evaluation of suspected small bowel bleeding (formerly obscure gastrointestinal bleeding)"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Raju GS, Gerson L, Das A, et al. American Gastroenterological Association (AGA) Institute medical position statement on obscure gastrointestinal bleeding. Gastroenterology 2007; 133:1694.</a></li><li><a class="nounderline abstract_t">Cook JD, Skikne BS. Iron deficiency: definition and diagnosis. J Intern Med 1989; 226:349.</a></li><li><a class="nounderline abstract_t">Rockey DC. Occult gastrointestinal bleeding. N Engl J Med 1999; 341:38.</a></li><li><a class="nounderline abstract_t">van Turenhout ST, Oort FA, Terhaar sive Droste JS, et al. Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results. Gastrointest Endosc 2012; 76:136.</a></li><li><a class="nounderline abstract_t">Lee MW, Pourmorady JS, Laine L. Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2020; 115:662.</a></li><li><a class="nounderline abstract_t">Bull-Henry K, Al-Kawas FH. Evaluation of occult gastrointestinal bleeding. Am Fam Physician 2013; 87:430.</a></li><li><a class="nounderline abstract_t">Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58:130.</a></li><li><a class="nounderline abstract_t">Chen YK, Gladden DR, Kestenbaum DJ, Collen MJ. Is there a role for upper gastrointestinal endoscopy in the evaluation of patients with occult blood-positive stool and negative colonoscopy? Am J Gastroenterol 1993; 88:2026.</a></li><li><a class="nounderline abstract_t">Geller AJ, Kolts BE, Achem SR, Wears R. The high frequency of upper gastrointestinal pathology in patients with fecal occult blood and colon polyps. Am J Gastroenterol 1993; 88:1184.</a></li><li><a class="nounderline abstract_t">Hsia PC, al-Kawas FH. Yield of upper endoscopy in the evaluation of asymptomatic patients with Hemoccult-positive stool after a negative colonoscopy. Am J Gastroenterol 1992; 87:1571.</a></li><li><a class="nounderline abstract_t">Bini EJ, Rajapaksa RC, Valdes MT, Weinshel EH. Is upper gastrointestinal endoscopy indicated in asymptomatic patients with a positive fecal occult blood test and negative colonoscopy? Am J Med 1999; 106:613.</a></li><li><a class="nounderline abstract_t">Rockey DC, Koch J, Cello JP, et al. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests. N Engl J Med 1998; 339:153.</a></li><li><a class="nounderline abstract_t">Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med 1993; 329:1691.</a></li><li><a class="nounderline abstract_t">Till SH, Grundman MJ. Prevalence of concomitant disease in patients with iron deficiency anaemia. BMJ 1997; 314:206.</a></li><li><a class="nounderline abstract_t">Kepczyk T, Kadakia SC. Prospective evaluation of gastrointestinal tract in patients with iron-deficiency anemia. Dig Dis Sci 1995; 40:1283.</a></li><li><a class="nounderline abstract_t">Shah A, Eqbal A, Moy N, et al. Upper GI endoscopy in subjects with positive fecal occult blood test undergoing colonoscopy: systematic review and meta-analysis. Gastrointest Endosc 2023; 97:1005.</a></li><li><a class="nounderline abstract_t">Hudak L, Jaraisy A, Haj S, Muhsen K. An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter 2017; 22.</a></li><li><a class="nounderline abstract_t">Gerson LB, Fidler JL, Cave DR, Leighton JA. ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding. Am J Gastroenterol 2015; 110:1265.</a></li><li><a class="nounderline abstract_t">Rockey DC. Occult and obscure gastrointestinal bleeding: causes and clinical management. Nat Rev Gastroenterol Hepatol 2010; 7:265.</a></li><li><a class="nounderline abstract_t">Sawhney MS, McDougall H, Nelson DB, Bond JH. Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs. Dig Dis Sci 2010; 55:1637.</a></li><li><a class="nounderline abstract_t">Greenberg PD, Cello JP, Rockey DC. Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease. Am J Med 1996; 100:598.</a></li><li><a class="nounderline abstract_t">Brenner H, Tao S, Haug U. Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA 2010; 304:2513.</a></li><li><a class="nounderline abstract_t">Kershenbaum A, Lavi I, Rennert G, Almog R. Fecal occult blood test performance indicators in warfarin-treated patients. Dis Colon Rectum 2010; 53:224.</a></li><li><a class="nounderline abstract_t">Zwas FR, Lyon DT. Occult GI bleeding in the alcoholic. Am J Gastroenterol 1996; 91:551.</a></li><li><a class="nounderline abstract_t">Bini EJ, Micale PL, Weinshel EH. Evaluation of the gastrointestinal tract in premenopausal women with iron deficiency anemia. Am J Med 1998; 105:281.</a></li><li><a class="nounderline abstract_t">Vannella L, Aloe Spiriti MA, Cozza G, et al. Benefit of concomitant gastrointestinal and gynaecological evaluation in premenopausal women with iron deficiency anaemia. Aliment Pharmacol Ther 2008; 28:422.</a></li></ol></div><div id="topicVersionRevision">Topic 2544 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17983811" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : American Gastroenterological Association (AGA) Institute medical position statement on obscure gastrointestinal bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2681511" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Iron deficiency: definition and diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10387941" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Occult gastrointestinal bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22726472" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31972617" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23547576" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Evaluation of occult gastrointestinal bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18322143" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8249968" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Is there a role for upper gastrointestinal endoscopy in the evaluation of patients with occult blood-positive stool and negative colonoscopy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8338085" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The high frequency of upper gastrointestinal pathology in patients with fecal occult blood and colon polyps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1442675" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Yield of upper endoscopy in the evaluation of asymptomatic patients with Hemoccult-positive stool after a negative colonoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10378617" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Is upper gastrointestinal endoscopy indicated in asymptomatic patients with a positive fecal occult blood test and negative colonoscopy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9664091" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8179652" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9022441" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Prevalence of concomitant disease in patients with iron deficiency anaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7781448" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prospective evaluation of gastrointestinal tract in patients with iron-deficiency anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36812947" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Upper GI endoscopy in subjects with positive fecal occult blood test undergoing colonoscopy: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27411077" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26303132" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20351759" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Occult and obscure gastrointestinal bleeding: causes and clinical management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20195757" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8678078" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21139112" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Low-dose aspirin use and performance of immunochemical fecal occult blood tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20087099" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Fecal occult blood test performance indicators in warfarin-treated patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8633507" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Occult GI bleeding in the alcoholic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9809688" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Evaluation of the gastrointestinal tract in premenopausal women with iron deficiency anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18498447" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Benefit of concomitant gastrointestinal and gynaecological evaluation in premenopausal women with iron deficiency anaemia.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
